🇨🇦 Canada · HS 9406 · official customs records

Buildings imports in Canada

Import activity for buildings (HS 9406) in Canada: declared value, sourcing mix, named importers and monthly trend from official customs records.

Declared value
$1.7B
CIF · January 2022 to August 2026
Customs records
10,078
January 2022 to August 2026
Top origin
🇺🇸 United States
66% of records
Origin markets
6
countries of origin
Named importers
–
not published by this source
Months of data
56
settled through Aug ’26

Monthly activity

last 24 months
$0$17.9M$35.7MSep ’24Nov ’24Jan ’25Mar ’25May ’25Jul ’25Sep ’25Nov ’25Jan ’26Mar ’26May ’26Jul ’26Aug ’26

Trade lanes

6 counterparty markets → Buildings imports
UNITED STATESCHINAISRAELNETHERLANDSESTONIAUNITED ARAB EMIRATESCANADA
🇺🇸 United States 66%🇨🇳 China 15%🇮🇱 Israel 6%

Where buildings is sourced from

share of records · declared CIF
🇺🇸 United States
66%
🇨🇳 China
15%
🇮🇱 Israel
6%
🇳🇱 Netherlands
6%
🇪🇪 Estonia
2%
🇦🇪 United Arab Emirates
1%
Share of declared value
United States: 69.1% · $1.1BUnited States69%China: 15.2% · $252.3MChina15%Israel: 6.1% · $102M6%Netherlands: 6.1% · $100.9M6%Estonia: 2.3% · $38.3MUnited Arab Emirates: 1.3% · $21.2M
Unlocks with a free account

Unit prices and price bands, ports and routes, the full importer list and history, contact details and the AI Analyst for buildings in Canada.

Create a free account

Common questions

Who imports buildings in Canada?

Exsigo tracks importers of buildings (HS 9406) in Canada from official customs records.

How much buildings does Canada import?

$1.7B of declared value across 10,078 customs records from January 2022 to August 2026, led by United States (66%).

Where does this data come from?

Directly from Canada's official government customs records. Exsigo ingests the primary source; nothing here is scraped from directories or estimated.

What unlocks with an account?

Unit prices and price bands, the complete importer list and shipment history, ports and routes, contact details and the AI Analyst unlock with a free Exsigo trial.